Advertisement

Current Diabetes Reports

, 19:133 | Cite as

Updates in Glycemic Management in the Hospital

  • Wasineenart Mongkolpun
  • Bruna Provenzano
  • Jean-Charles PreiserEmail author
Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Hospital Management of Diabetes

Abstract

Purpose of Review

To provide an update of glycemic management during metabolic stress related to surgery or critical illness.

Recent Findings

There is a clear association between severe hyperglycemia, hypoglycemia, and high glycemic variability and poor outcomes of postoperative or critically ill patients. However, the impressive beneficial effects of tight glycemic management (TGM) by intensive insulin therapy reported in one study were never reproduced. Hence, the recommendation of TGM is now replaced by more liberal blood glucose (BG) targets (< 180 mg/dL or 10 mM). Recent data support the concept of targeting individualized blood glucose (BG) values according to the presence of diabetes mellitus/chronic hyperglycemia, the presence of brain injury, and the time from injury.

Summary

A more liberal glycemic management goal is currently advised during metabolic stress and could be switched to individualized glycemic management once validated by prospective trials.

Keywords

Stress hyperglycemia Insulin resistance Critically ill Postoperative care Insulin Glucose 

Notes

Compliance with Ethical Standards

Conflict of Interest

Wasineenart Mongkolpun and Bruna Provenzano declare that they have no conflict of interest.

Jean-Charles Preiser reports personal fees from Optiscan, Edwards Lifesciences, and Medtronic.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798–807.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–21.PubMedGoogle Scholar
  3. 3.
    van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.Google Scholar
  4. 4.
    Preiser J (2010) 72 - Should Blood Glucose Be Tightly Controlled in the Intensive Care Unit? In: Deutschman CS, Neligan PJ (eds) Evidence-Based Practice of Critical Care. Saunders, Philadelphia, an imprint of Elsevier Inc., pp 505–508Google Scholar
  5. 5.
    NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.Google Scholar
  6. 6.
    Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.PubMedGoogle Scholar
  7. 7.
    De La Rosa GD, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12:R120.Google Scholar
  8. 8.
    Arabi Y, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190–7.PubMedGoogle Scholar
  9. 9.
    Kalfon P, Giraudeau B, Ichai C, et al. Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial. Intensive Care Med. 2014;40:171–81.PubMedGoogle Scholar
  10. 10.
    COIITSS Study Investigators, Annane D, Cariou A, Maxime V, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303:341–8.Google Scholar
  11. 11.
    Brunkhorst FM, Engel C, Bloos F, German competence network Sepsis (SepNet), et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.PubMedGoogle Scholar
  12. 12.
    Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multi-Centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738–48.PubMedGoogle Scholar
  13. 13.
    Rosso C, Corvol JC, Pires C, Crozier S, Attal Y, Jacqueminet S, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke. 2012;43:2343–9.PubMedGoogle Scholar
  14. 14.
    Bilotta F, Spinelli A, Giovannini F, et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol. 2007;19:156–60.PubMedGoogle Scholar
  15. 15.
    Bilotta F, Caramia R, Paoloni FP, et al. Safety and efcacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology. 2009;110:611–9.PubMedGoogle Scholar
  16. 16.
    de Mulder M, Umans VA, Cornel JH, et al. Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern Med. 2013;173:1896–904.PubMedGoogle Scholar
  17. 17.
    Wallia A, Schmidt K, Oakes DJ, et al. Glycemic control reduces infections in post-liver transplant patients: results of a prospective, Randomized Study. J Clin Endocrinol Metab. 2017;102:451–9.PubMedGoogle Scholar
  18. 18.
    The NICE-SUGAR. Study investigators hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108–18.Google Scholar
  19. 19.
    • Wang YY, Hu SF, Ying HM, Chen L, Li HL, Tian F, et al. Postoperative tight glycemic control significantly reduces postoperative infection rates in patients undergoing surgery: a meta-analysis. BMC Endocr Disord. 2018;18:42. An updated systematic review on the effect of tight glycemic control on postoperative infections. PubMedPubMedCentralGoogle Scholar
  20. 20.
    • Kang ZQ, Huo JL, Zhai XJ. Effects of perioperative tight glycemic control on postoperative outcomes: a meta-analysis. Endocr Connect. 2018;7:R316–27. An updated systematic review on the effect of tight glycemic control on postoperative complications. PubMedPubMedCentralGoogle Scholar
  21. 21.
    • Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med. 2017;43:1–15. An important comprehensive analysis of the available clinical data on tight glycemic control in intensive care medicine. PubMedGoogle Scholar
  22. 22.
    Kao LS, Meeks D, Moyer VA, Lally KP. Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev. 2009;3:CD006806.Google Scholar
  23. 23.
    Preiser JC, Chase JG, Hovorka R, et al. Glucose control in the ICU: a continuing story. J Diabetes Sci Technol. 2016;10:1372–81.PubMedPubMedCentralGoogle Scholar
  24. 24.
    • Olariu E, Pooley N, Danel A, Miret M, Preiser JC. A systematic scoping review on the consequences of stress-related hyperglycaemia. PLoS One. 2018;13:e0194952. A systematic review of the available data on the associations between hyperglycemia and outcomes in the critically ill. PubMedPubMedCentralGoogle Scholar
  25. 25.
    American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care. 2017;40(Suppl. 1):S11–24.Google Scholar
  26. 26.
    • Cheisson G, Jacqueminet S, Cosson E, et al. Perioperative management of adult diabetic patients. Review of hyperglycaemia: definitions and pathophysiology. Anaesth Crit Care Pain Med. 2018;37(Suppl 1):S5–8. A practical and updated approach of the management of diabetes before and after surgery. PubMedGoogle Scholar
  27. 27.
    Preiser JC, Ichai C, Orban JC, Groeneveld AB. Metabolic response to the stress of critical illness. Br J Anaesth. 2014;113:945–54.PubMedGoogle Scholar
  28. 28.
    Preiser JC. Restoring normoglycaemia: not so harmless. Crit Care. 2008;12:116.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Lena D, Kalfon P, Preiser JC, Ichai C. Glycemic control in the intensive care unit and during the postoperative period. Anesthesiology. 2011;114:438–44.PubMedGoogle Scholar
  30. 30.
    Uyttendaele V, Dickson JL, Shaw GM, Desaive T, Chase JG. Untangling glycaemia and mortality in critical care. Crit Care. 2017;21:152.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Soeters MR, Soeters PB. The evolutionary benefit of insulin resistance. Clin Nutr. 2012;31:1002–7.PubMedGoogle Scholar
  32. 32.
    Harp JB, Yancopoulos GD, Gromada J. Glucagon orchestrates stress-induced hyperglycaemia. Diabetes Obes Metab. 2016;18:648–53.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Nielsen ST, Janum S, Krogh-Madsen R, Solomon TP, Møller K. The incretin effect in critically ill patients: a case-control study. Crit Care. 2015;19:402.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Jamaludin UK, Docherty PD, Chase JC, et al. Observation of incretin effects during enteral feed transitions of critically ill patients. e-SPEN J. 2012;7:e154–9.Google Scholar
  35. 35.
    • Ding W, Xu L, Zhang L, et al. Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus. BMC Med Genet. 2018;19:38. A systematic review of the association studies confirming the presence of a single polymorphism as a risk factor for type 2 diabetes mellitus across all ethnicities. PubMedPubMedCentralGoogle Scholar
  36. 36.
    • Ben Hamou A, Kipnis E, Elbaz A, et al. Association of transcription factor 7-like 2 gene (TCF7L2) polymorphisms with stress-related hyperglycaemia (SRH) in intensive care and resulting outcomes: The READIAB study. Diabetes Metab. 2019; A large-scale study assessing the presence of a single polymorphism as a risk factor for stress hyperglycemia.  https://doi.org/10.1016/j.diabet.2019.05.001.
  37. 37.
    Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med. 2012;40:3180–8.PubMedGoogle Scholar
  38. 38.
    Falciglia M, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37:3001–9.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care. 2013;17:R37.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Green JP, Berger T, Garg N, et al. Hyperlactatemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis. Acad Emerg Med. 2012;19:1268–75.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Kaukonen KM, Bailey M, Egi M, Orford N, Glassford NJ, Marik PE, et al. Stress hyperlactatemia modifies the relationship between stress hyperglycemia and outcome: a retrospective observational study. Crit Care Med. 2014;42(6):1379–85.PubMedGoogle Scholar
  42. 42.
    Freire Jorge P, Wieringa N, de Felice E, van der Horst ICC, Oude Lansink A, Nijsten MW. The association of early combined lactate and glucose levels with subsequent renal and liver dysfunction and hospital mortality in critically ill patients. Crit Care. 2017;21:218.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Egi M, Bellomo R, Stachowski E. Etal. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36:2249–55.PubMedGoogle Scholar
  44. 44.
    Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care. 2013;17:R52.PubMedPubMedCentralGoogle Scholar
  45. 45.
    • van Vught LA, Holman R, de Jonge E, et al. Diabetes is not associated with increased 90-day mortality risk in critically ill patients with sepsis. Crit Care Med. 2017;45:e1026–35. Analysis of a national database showing differences between the associations of dysglycemia and outcomes according to the presence of diabetes. PubMedGoogle Scholar
  46. 46.
    Van den Berghe G, Wilmer A, Milants I. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–9.PubMedGoogle Scholar
  47. 47.
    Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078–86.PubMedGoogle Scholar
  48. 48.
    Mesotten D, Preiser JC, Kosiborod M. Glucose management in critically ill adults and children. Lancet Diabetes Endocrinol. 2015;3:723–33.PubMedGoogle Scholar
  49. 49.
    • Egi M, Krinsley JS, Maurer P, et al. Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortality. Intensive Care Med. 2016;42:562–71. Multinational multicenter observational study showing differences between the associations of dysglycemia and outcomes according to the admission HbA1c level. PubMedGoogle Scholar
  50. 50.
    • Magee F, Bailey M, Pilcher DV, Mårtensson J, Bellomo R. Early glycemia and mortality in critically ill septic patients: Interaction with insulin-treated diabetes. J Crit Care. 2018;45:170–7. Analysis of a large database of septic patients showing different relationship between hospital mortality and highest glucose levels and glycemic variability in the first 24 h, according to the presence of insulin-treated diabetes. PubMedGoogle Scholar
  51. 51.
    Egi M, Bellomo R, Stachowski E, et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med. 2011;39:105–11.PubMedGoogle Scholar
  52. 52.
    Roberts GW, Quinn SJ, Valentine N. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100:4490–7.PubMedGoogle Scholar
  53. 53.
    Preiser JC, Lheureux O, Prevedello D. A step toward personalized glycemic control. Crit Care Med. 2018;46:1019–20.PubMedGoogle Scholar
  54. 54.
    Plummer MP, Bellomo R, Cousins CE, et al. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. 2014;40:973–80.PubMedGoogle Scholar
  55. 55.
    • Krinsley JS, Preiser JC, Hirsch IB. Safety and efficacy of personalized glycemic control in critically ill patients: a 2-year before and after interventional trial. Endocr Pract. 2017;23:318–30. A proof-of concept clinical investigation showing an improvement of survival when a higher blood glucose target was applied in patients with chronic hyperglycemia. PubMedGoogle Scholar
  56. 56.
    Bosarge PL, Shoultz TH, Griffin RL, Kerby JD. Stress-induced hyperglycemia is associated with higher mortality in severe traumatic brain injury. J Trauma Acute Care Surg. 2015;79:289–94.PubMedGoogle Scholar
  57. 57.
    • Saxena A, Anderson CS, Wang X, et al. Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study. Stroke. 2016;47:682–8. Analysis of a large cohort of patients with intracerebral hemorrhage enrolled in an interventional trial on blood pressure management, showing an association between admission hyperglycemia, diabetes mellitus and poor nerological outcome. PubMedGoogle Scholar
  58. 58.
    Green DM, O'Phelan KH, Bassin SL, Chang CW, Stern TS, Asai SM. Intensive versus conventional insulin therapy in critically ill neurologic patients. Neurocrit Care. 2010;13:299–306.PubMedGoogle Scholar
  59. 59.
    Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology. 2009;110:611–9.PubMedGoogle Scholar
  60. 60.
    Meier R, Béchir M, Ludwig S, et al. Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury. Crit Care. 2008;12:R98.PubMedPubMedCentralGoogle Scholar
  61. 61.
    Lheureux O, Prevedello D, Preiser JC. Update on glucose in critical care. Nutrition. 2019;59:14–20.  https://doi.org/10.1016/j.nut.2018.06.027.CrossRefPubMedGoogle Scholar
  62. 62.
    American Diabetes Association. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S173–81.Google Scholar
  63. 63.
    • Cosson E, Catargi B, Cheisson G, Jacqueminet S, Ichai C, Leguerrier AM, et al. Practical management of diabetes patients before, during and after surgery: A joint French diabetology and anaesthesiology position statement. Diabetes Metab. 2018;44(3):200–16. A practical and updated approach of the management of diabetes before and after surgery. PubMedGoogle Scholar
  64. 64.
    Ichai C, Preiser JC, Société Française d'Anesthésie-Réanimation, Société de Réanimation de langue Française, & Experts group. International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care. 2010;14(5):R166.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Leelarathna L, English SW, Thabit H, et al. Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care. 2013;17:R159.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Wasineenart Mongkolpun
    • 1
  • Bruna Provenzano
    • 1
  • Jean-Charles Preiser
    • 1
    Email author
  1. 1.Department of Intensive CareErasme University Hospital, Université Libre de BruxellesBrusselsBelgium

Personalised recommendations